The cisterna chyli is a small, sac-like dilation at the very start of the thoracic duct, the body’s largest lymphatic vessel. It sits deep in the abdomen, tucked behind the aorta near the spine, and serves as a collecting reservoir where lymphatic fluid from the intestines, liver, and lower body converges before being channeled upward through the chest and eventually returned to the bloodstream. Its name, Latin for “cistern of chyle,” reflects its main cargo: chyle, the milky, fat-rich lymphatic fluid produced during digestion.
Where It Sits in the Body
The cisterna chyli occupies a tight space called the retrocrural area, which lies between the muscular pillars (crura) of the diaphragm and the front of the spine. In most people who have one, it sits to the right of the abdominal aorta. A cadaveric study found it positioned at the L1–L2 vertebral level in about 63% of specimens, with smaller percentages located at progressively higher vertebral levels up toward T9–T10.1PubMed. Cisterna chyli: a detailed anatomic investigation That places it roughly at the level of your belly button or just above, though deep enough that you would never feel it from the outside.
In imaging terms, the cisterna chyli shows up as a small tubular or oval structure. On CT scans it can be surprisingly hard to spot. One study reviewing over 400 CT cases identified it in fewer than 2% of patients, partly because of its small size and partly because its fluid density can blend into surrounding tissue.2Clinical Imaging. The cisterna chyli: Incidence and characteristics on CT MRI tends to be better at picking it up. A study using routine abdominal MRI described it as a normal finding in the retrocrural space and emphasized that radiologists should recognize it so they don’t mistake it for something pathological like a lymph node or a mass.3PubMed. Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space
Not Everyone Has One
Here is the part that surprises most people: a substantial number of humans do not have a clearly identifiable cisterna chyli at all. A meta-analysis pooling data from over 1,400 anatomical specimens found that only about 55% had a recognizable cisterna chyli.4PubMed Central. The Anatomy of the Thoracic Duct and Cisterna Chyli: A Meta-Analysis with Surgical Implications In the remaining cases, the lymphatic tributaries from the gut and lower body simply converge into the thoracic duct without forming a distinct sac. Think of it like a river junction: sometimes tributaries meet at a wide pool before flowing into the main channel, and sometimes they just merge directly into it.
Even among people who do have one, the cisterna chyli varies considerably. A systematic review catalogued sizes ranging from about 2 to 32 mm in diameter and 13 to 80 mm in length, with differences in shape (round, oval, spindle-like) and in which lymphatic tributaries feed into it.5PubMed. The cisterna chyli: a systematic review of definition, prevalence, and anatomy The meta-analysis found an average length of roughly 18 mm, or a bit under an inch.4PubMed Central. The Anatomy of the Thoracic Duct and Cisterna Chyli: A Meta-Analysis with Surgical Implications This variability matters clinically because surgeons and interventional radiologists working in the area can’t assume they know exactly where it will be, or even that it will be there.
What Chyle Actually Is
The fluid the cisterna chyli collects and holds is chyle, and it deserves its own explanation because it is far more than simple body fluid. Chyle is a lymphatic fluid produced during digestion that contains fats packaged into particles called chylomicrons, along with proteins, fat-soluble vitamins, electrolytes, and a high concentration of white blood cells, primarily T-lymphocytes and immunoglobulins. It has a characteristic milky, opalescent appearance that becomes most obvious after a fatty meal.
The reason chyle is so fat-rich has to do with how your gut handles dietary fats. Unlike sugars and amino acids, which are absorbed directly into blood capillaries and sent to the liver via the portal vein, most dietary fats take a different route. They get assembled into chylomicrons by cells lining the small intestine and then sent into specialized lymphatic vessels called lacteals. From the lacteals, chyle travels through a series of larger lymphatic trunks before arriving at the cisterna chyli. The cisterna chyli is essentially the first major pit stop on this journey. From there, chyle flows upward through the thoracic duct, which runs along the spine through the chest and empties into the venous system near the junction of the left internal jugular and subclavian veins, just below the left collarbone.
This routing means the cisterna chyli handles a large share of the body’s daily fat and immune-cell traffic. Disrupting it, whether through disease, surgery, or trauma, can have consequences that are disproportionate to the structure’s small size.
How Lymph Moves Through It
One question people often have about the lymphatic system in general is how fluid moves through it without a dedicated pump like the heart. The cisterna chyli and the thoracic duct above it rely on several forces. Breathing creates pressure changes in the chest and abdomen that can push lymph along. Contractions of the smooth muscle in the walls of larger lymphatic vessels provide some propulsion. Movements of the body and pulsations of nearby arteries also help.
That said, the relative importance of each force is still debated. A literature review found that breathing influenced thoracic duct flow or pressure in most human studies examined, but circulatory forces showed less consistent effects. The researchers noted that findings across studies have been inconsistent, largely because of differences in how the measurements were done.6PubMed Central. The physiology of thoracic duct pressure and flow: A review of the literature What is clear is that the cisterna chyli is not simply a passive bag. Pressure within it can fluctuate, and those fluctuations interact with the pressures in surrounding veins and abdominal organs in ways that affect how well lymph drains from the gut.
Animal experiments have shown that artificially raising pressure inside the cisterna chyli while simultaneously raising portal vein pressure significantly increases fluid leakage into the abdominal cavity, producing ascites.7PubMed. Flow in lymphatic networks: interaction between hepatic and intestinal lymph vessels This kind of research helps explain why anything that backs up flow from the cisterna chyli tends to cause problems downstream.
When the Cisterna Chyli Gets Damaged
Because of its deep location right in front of the spine, the cisterna chyli is vulnerable during any surgery involving the retroperitoneal space, the area behind the abdominal cavity’s lining.8PubMed Central. Spontaneous healing of retroperitoneal chylous leakage following anterior lumbar spinal surgery: a case report and literature review This includes certain spine operations, kidney surgeries, and procedures to remove lymph nodes around the aorta for cancer staging. Esophageal surgery is another common culprit, because surgeons frequently clip the thoracic duct during the operation. If chyle can no longer travel upward through the thoracic duct, it backs up under pressure and can leak from the cisterna chyli or its nearby tributaries.
One case report illustrated this vividly. After a patient underwent esophageal cancer surgery that included clipping the thoracic duct, chyle backed up into the cisterna chyli and began leaking into the abdominal cavity. Imaging showed that because the upward path was blocked, lymph refluxed downward from the cisterna chyli and leaked through a lymphatic vessel that had been disrupted during earlier lymph node removal.9PubMed Central. A case of chylous ascites caused by reflux from the cisterna chyli to the disrupted common iliac lymphatic vessel: fluoroscopic records during intranodal lymphangiography The case highlighted how chyle can find unexpected routes out of the lymphatic system when its normal pathway is blocked.
Chylous Ascites and Chylothorax
The two main clinical problems linked to cisterna chyli dysfunction are chylous ascites and chylothorax, referring to chyle leaking into the abdominal cavity or the chest cavity, respectively. Several mechanisms can cause these conditions. Direct injury to the cisterna chyli or thoracic duct during surgery is the most straightforward. But cancers can also obstruct lymph flow by causing scarring in lymph nodes that sit between the gut and the cisterna chyli, backing up pressure in smaller lymphatic channels until they leak. Over time, that increased pressure can deposit collagen in the walls of lymphatic vessels, further impairing their ability to absorb and transport fluid.10PubMed Central. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment
Congenital abnormalities also play a role. Some people are born with abnormally dilated retroperitoneal lymphatic vessels, sometimes called megalymphatics, which can ooze lymphatic fluid into the abdominal cavity. Whether or not a recognizable cisterna chyli exists in these patients, the network of lymphatic tributaries in the same anatomical region is involved.
Chylous leaks matter not just because of the fluid buildup itself but because of what is being lost. Chronic chyle loss depletes the body of fats, proteins, fat-soluble vitamins, and immune cells. Patients with unresolved chylous ascites or chylothorax can become malnourished and immunocompromised, which is why treatment is taken seriously even when the leak volume is modest.
Treating Leaks Through Interventional Radiology
For decades, the standard treatment for a high-output chyle leak was surgical ligation, which means tying off the thoracic duct. Over the past 25 years, minimally invasive alternatives have emerged that target the cisterna chyli directly. The basic approach involves puncturing the cisterna chyli through the skin under imaging guidance, threading a catheter into it, and then either embolizing the leaking duct with coils and glue or repeatedly disrupting the nearby lymphatic vessels with a needle to trigger scarring and closure.
An early study demonstrated that lymphatic ducts as small as 2 to 3 mm could be catheterized successfully through the cisterna chyli. In that series, four out of five patients avoided reoperation.11Journal of Vascular and Interventional Radiology. Diagnosis and Treatment of Postoperative Chyle Leakage via Percutaneous Transabdominal Catheterization of the Cisterna Chyli: A Preliminary Study Later work showed that even when the cisterna chyli cannot be identified (remember, nearly half of people lack a visible one), the percutaneous approach can still succeed through needle disruption of lymphatic channels in the area where it would normally sit.12Journal of Vascular and Interventional Radiology. Percutaneous Treatment of High-Output Chylothorax with Embolization or Needle Disruption Technique
Some centers have begun to adopt this approach as a first-line therapy for severe chyle leaks, particularly those occurring after esophageal cancer surgery, reserving open surgery for cases where catheter-based treatment fails.13PubMed. Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae The cisterna chyli’s role here is practical: it is the access point. Interventional radiologists use it as an entry window into the central lymphatic system, in much the same way a large vein might be used to access the heart for cardiac procedures.
Its Role in Drug Absorption
The cisterna chyli’s function as a fat-transport conduit has pharmaceutical implications that are receiving growing attention. When you swallow a fat-soluble drug, it can be absorbed by the same intestinal lymphatic route that dietary fats take, traveling through lacteals and lymphatic trunks into the cisterna chyli and then up the thoracic duct before entering the bloodstream. This is significant because drugs that travel through the lymphatic system bypass the liver’s first-pass metabolism, the process by which the liver breaks down a large fraction of many drugs before they reach the general circulation. By skipping that step, lymphatic transport can increase how much of a drug actually reaches active levels in the blood.14PubMed Central. Intestinal transport as a potential determinant of drug bioavailability
Pharmaceutical researchers have explored this by designing drug formulations that hitch a ride on chylomicrons, the same fat-carrying particles that make chyle milky. The idea is to package drugs in a way that encourages the intestine to route them through the lymphatic system rather than the portal vein. In practical terms, this means the cisterna chyli acts as part of an alternative highway for certain medications, one that avoids the liver’s tollbooth. For drugs with poor oral bioavailability due to heavy first-pass metabolism, lymphatic delivery through the gut-cisterna chyli-thoracic duct pathway could improve effectiveness at lower doses.
The Cisterna Chyli in Other Species
The cisterna chyli is not unique to humans. It has been identified across many mammals, though its size, shape, and exact position vary by species. In domestic cats, for example, the cisterna chyli sits slightly lower than in humans, at the level of the L2 to L4 vertebrae, dorsal to (above) the abdominal aorta rather than to one side. In cats it was described as an oval sac roughly 2.5 cm long, receiving lumbar lymphatic trunks from behind and visceral or intestinal trunks from below.15Revue Médicale Vétérinaire. Conformation of Cisterna chyli in cats (Felis catus)
Veterinary knowledge of the cisterna chyli matters for the same reasons as in human medicine. Cats and dogs can develop chylothorax, and surgical options include ligation of the thoracic duct. Knowing where the cisterna chyli sits and what it looks like in a given species is essential for planning those operations. The comparative anatomy also reinforces a broader point: the cisterna chyli is a conserved mammalian structure whose function, collecting and forwarding chyle, is fundamental enough to have been maintained across species despite the considerable differences in body size and gut anatomy between, say, a house cat and a human.
Why Imaging the Central Lymphatic System Is Challenging
Unlike arteries and veins, which are relatively easy to visualize with standard contrast-enhanced imaging, the lymphatic system has historically been difficult to see. The cisterna chyli’s low detection rate on CT, mentioned earlier, is one example. The structure is small, its fluid has a density close to water, and it does not enhance with standard intravenous contrast dyes because contrast agents reach it through lymphatic channels, not blood vessels.
Specialized techniques have been developed to get around this problem. Intranodal lymphangiography involves injecting an oily contrast agent directly into a lymph node, usually in the groin, and then watching under fluoroscopy as the contrast travels up through the lymphatic system. This is the technique that was used in the chylous ascites case discussed above, and it can reveal the cisterna chyli and any sites of chyle leakage in real time. More recently, CT lymphangiography and non-contrast MR lymphangiography have emerged as tools for imaging central lymphatic abnormalities.16PubMed. CT Lymphangiography and Nonenhanced Magnetic Resonance Lymphangiography of Central Lymphatic Abnormalities in Patients with Central Conducting Lymphatic Anomalies These advances have made it possible to map the lymphatic system with greater precision, which in turn has made interventional procedures targeting the cisterna chyli more feasible and safer.
The practical impact is significant. Two decades ago, a surgeon operating on a chyle leak often had limited information about the patient’s specific lymphatic anatomy. Today, detailed imaging can show whether a cisterna chyli is present, where it sits, and exactly where the leak originates, all before any incision is made. For a structure as variable as the cisterna chyli, that kind of pre-procedural mapping can be the difference between a targeted, successful intervention and an exploratory operation.